Literature DB >> 6699671

Karnofsky performance status revisited: reliability, validity, and guidelines.

C C Schag, R L Heinrich, P A Ganz.   

Abstract

Little research has been conducted documenting the reliability and validity of the Karnofsky Performance Status (KPS) scale, and guidelines based on empirical data do not exist to govern its use. Two hundred ninety-three cancer patients completed a questionnaire that assesses their physical and psychosocial difficulties. Physicians rated patients on the KPS and a subsample of 75 patients was used to evaluate interrater reliability. Analyses were conducted to evaluate the interrater reliability and construct validity of the KPS. The KPS was shown to have good reliability and validity. Detailed examination of the reliability data suggested areas in which physicians err in their judgments. Multiple regression techniques were used to empirically identify seven behaviorally based questions that would be helpful in predicting KPS scores. The seven variables included weight loss, weight gain, reduced energy, difficulty walking, driving, grooming, and working part time. An interview approach with behaviorally based guidelines is presented using these variables to obtain relevant data and make more accurate KPS ratings. With the approach suggested and the guidelines presented, oncologists may train themselves to use the KPS in a standard way, which should increase reliability and validity of the KPS and has implications for patients and research studies that use KPS as a stratifying variable.

Entities:  

Mesh:

Year:  1984        PMID: 6699671     DOI: 10.1200/JCO.1984.2.3.187

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  363 in total

1.  Lessons from traumatic head injury for assessing functional status after brain tumour.

Authors:  J T Lindsay Wilson
Journal:  J Neurooncol       Date:  2012-02-11       Impact factor: 4.130

2.  Family physician involvement in cancer care follow-up: the experience of a cohort of patients with lung cancer.

Authors:  Michèle Aubin; Lucie Vézina; René Verreault; Lise Fillion; Eveline Hudon; François Lehmann; Yvan Leduc; Rénald Bergeron; Daniel Reinharz; Diane Morin
Journal:  Ann Fam Med       Date:  2010 Nov-Dec       Impact factor: 5.166

3.  Evaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma.

Authors:  Ting Jin; Xiao-Zhong Chen; Jian-Jiang Liu
Journal:  Oncol Lett       Date:  2015-06-10       Impact factor: 2.967

Review 4.  Health-Related Quality of Life After Spine Surgery for Primary Bone Tumour.

Authors:  Raphaële Charest-Morin; Nicolas Dea; Charles G Fisher
Journal:  Curr Treat Options Oncol       Date:  2016-02

5.  Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.

Authors:  Guido H Jajamovich; Chandni R Valiathan; Razvan Cristescu; Sangeetha Somayajula
Journal:  J Neurooncol       Date:  2016-07-08       Impact factor: 4.130

6.  Psychometric properties of Functional Assessment of Cancer Therapy-Prostate (FACT-P) in Chinese patients with prostate cancer.

Authors:  Carlos K H Wong; Edmond P H Choi; James H L Tsu; Brian S H Ho; Ada T L Ng; W Y Chin; M K Yiu
Journal:  Qual Life Res       Date:  2015-04-16       Impact factor: 4.147

7.  Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.

Authors:  Kent A Robertson; Grzegorz Nalepa; Feng-Chun Yang; Daniel C Bowers; Chang Y Ho; Gary D Hutchins; James M Croop; Terry A Vik; Scott C Denne; Luis F Parada; Cynthia M Hingtgen; Laurence E Walsh; Menggang Yu; Kamnesh R Pradhan; Mary K Edwards-Brown; Mervyn D Cohen; James W Fletcher; Jeffrey B Travers; Karl W Staser; Melissa W Lee; Marcie R Sherman; Cynthia J Davis; Lucy C Miller; David A Ingram; D Wade Clapp
Journal:  Lancet Oncol       Date:  2012-10-23       Impact factor: 41.316

8.  Follow-up after intensive care: a single center study.

Authors:  Reidar Kvåle; Atle Ulvik; Hans Flaatten
Journal:  Intensive Care Med       Date:  2003-11-04       Impact factor: 17.440

9.  Development of a new lingual range-of-motion assessment scale: normative data in surgically treated oral cancer patients.

Authors:  C L Lazarus; H Husaini; A S Jacobson; J K Mojica; D Buchbinder; D Okay; M L Urken
Journal:  Dysphagia       Date:  2014-05-09       Impact factor: 3.438

10.  Geriatric assessment-identified deficits in older cancer patients with normal performance status.

Authors:  Trevor A Jolly; Allison M Deal; Kirsten A Nyrop; Grant R Williams; Mackenzi Pergolotti; William A Wood; Shani M Alston; Brittaney-Belle E Gordon; Samara A Dixon; Susan G Moore; W Chris Taylor; Michael Messino; Hyman B Muss
Journal:  Oncologist       Date:  2015-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.